Why Should You Put Veracyte Inc (NASDAQ: VCYT) On Your Portfolio?
The Vanguard Group, Inc. recently announced the acquisition of new stake in Veracyte Inc (NASDAQ:VCYT). The institutional investor has increased its shareholding in the Healthcare company by 0.32% to 6.94 million shares with purchase of 22213.0 shares. This fresh investment now brings its stake to 9.50% valued currently at $190.92 million. In addition, BlackRock Fund […]
These Numbers Could Change Investor Views For Veracyte Inc (NASDAQ: VCYT)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Veracyte Inc (NASDAQ:VCYT). The institutional investor has increased its shareholding in the Healthcare company by 0.32% to 6.94 million shares with purchase of 22213.0 shares. This fresh investment now brings its stake to 9.50% valued currently at $177.66 million. In addition, BlackRock Fund […]